Literature DB >> 35186157

KSNM60 in Nuclear Endocrinology: from the Beginning to the Future.

Chae Moon Hong1, Young Jin Jeong2, Hae Won Kim3, Byeong-Cheol Ahn1.   

Abstract

Nuclear endocrinology is the main ignitor for founding the Korean Society of Nuclear Medicine (KSNM) in the early 1960s by outstanding pioneering medical doctors. Management of thyroid diseases required nuclear medicine technology in the early days of the KSNM and was rapidly developed by advancements in nuclear medicine technology. Nuclear thyroidology remains one of the main clinical applications in nuclear medicine worldwide. Nuclear medicine technology provides essential information for diagnosing and assessing diseases of the parathyroid glands, pituitary gland, and neuroendocrine tumors (NETs). In addition, therapeutic nuclear medicine is essential for managing nonresectable NETs. Nuclear endocrinology remains a major section in clinical nuclear medicine, and members of the KSNM have contributed to progressing better management of benign and malignant endocrine diseases. This review summarizes the historical activities and milestone contributions to nuclear endocrinology made by the members of the KSNM over the past 60 years to congratulate the KSNM on its 60-year anniversary.
© The Author(s), under exclusive licence to Korean Society of Nuclear Medicine 2021.

Entities:  

Keywords:  Neuroendocrine tumor; Nuclear endocrinology; Parathyroid gland; Pituitary gland; Thyroid gland

Year:  2022        PMID: 35186157      PMCID: PMC8828839          DOI: 10.1007/s13139-021-00728-0

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  61 in total

1.  Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.

Authors:  J K Chung; Y So; J S Lee; C W Choi; S M Lim; D S Lee; S W Hong; Y K Youn; M C Lee; B Y Cho
Journal:  J Nucl Med       Date:  1999-06       Impact factor: 10.057

2.  Incidental focal 18F-FDG uptake in the pituitary gland: clinical significance and differential diagnostic criteria.

Authors:  Seung Hyup Hyun; Joon Young Choi; Kyung-Han Lee; Yearn Seong Choe; Byung-Tae Kim
Journal:  J Nucl Med       Date:  2011-03-18       Impact factor: 10.057

Review 3.  Genetic basis of endocrine disease: pituitary tumor pathogenesis.

Authors:  I Shimon; S Melmed
Journal:  J Clin Endocrinol Metab       Date:  1997-06       Impact factor: 5.958

4.  A Novel Tyrosine Kinase Inhibitor Can Augment Radioactive Iodine Uptake Through Endogenous Sodium/Iodide Symporter Expression in Anaplastic Thyroid Cancer.

Authors:  Ji Min Oh; Se Hwan Baek; Prakash Gangadaran; Chae Moon Hong; Ramya Lakshmi Rajendran; Ho Won Lee; Liya Zhu; Arunnehru Gopal; Senthilkumar Kalimuthu; Shin Young Jeong; Sang-Woo Lee; Jaetae Lee; Byeong-Cheol Ahn
Journal:  Thyroid       Date:  2020-02-14       Impact factor: 6.568

5.  Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma.

Authors:  J J Min; J K Chung; Y J Lee; J M Jeong; D S Lee; J J Jang; M C Lee; B Y Cho
Journal:  Eur J Nucl Med       Date:  2001-05

6.  Prognostic value of preoperative 18F-FDG PET/CT in papillary thyroid cancer patients with a high metastatic lymph node ratio: a multicenter retrospective cohort study.

Authors:  Seong Young Kwon; Eun Kyoung Choi; Eun Jung Kong; Ari Chong; Jung-Min Ha; Kyung Ah Chun; Ihn Ho Cho; Hee-Seung Bom; Jung-Joon Min; Jahae Kim; Ho-Chun Song; Joo Hyun O; Sung Hoon Kim
Journal:  Nucl Med Commun       Date:  2017-05       Impact factor: 1.690

7.  Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography.

Authors:  A Reum Chun; Hye Min Jo; Seoung Ho Lee; Hong Woo Chun; Jung Mi Park; Kyu Jin Kim; Chan Hee Jung; Ji Oh Mok; Sung Koo Kang; Chul Hee Kim; Bo Yeon Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2014-07-18

8.  Diagnostic values of F-18 FDG PET or PET/CT, CT, and US for Preoperative Lymph Node Staging in Thyroid Cancer: A Network Meta-Analysis.

Authors:  Keunyoung Kim; Sung-Ryul Shim; Sang-Woo Lee; Seong-Jang Kim
Journal:  Br J Radiol       Date:  2021-02-17       Impact factor: 3.039

9.  Deep learning enables automated localization of the metastatic lymph node for thyroid cancer on 131I post-ablation whole-body planar scans.

Authors:  MuthuSubash Kavitha; Chang-Hee Lee; KattakkaliSubhashdas Shibudas; Takio Kurita; Byeong-Cheol Ahn
Journal:  Sci Rep       Date:  2020-05-08       Impact factor: 4.379

10.  Systemic Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors in Korea: Literature Review and Expert Opinion.

Authors:  Changhoon Yoo; Chung Ryul Oh; Seung-Tae Kim; Woo Kyun Bae; Hye-Jin Choi; Do-Youn Oh; Myung-Ah Lee; Baek-Yeol Ryoo
Journal:  Cancer Res Treat       Date:  2020-12-29       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.